Events for Doctors
Stem Cells & Cancer: Exploring the Heterogeneity of Cancer Cells and Relevance to Therapy
Gordon Research Conference on Stem Cells and Cancer
Feb. 15-20, 2105
Ventura, CA
www.grc.org
The Fifth Gordon Conference on Stems Cells and Cancer will focus on understanding how cancer stem cells behave and interact with their niche. Tumors investigated include melanoma, leukemia, lymphoma, muscle tumors, colon cancer, breast cancer, squamous cell cancer, medullar blastoma, and others. The interaction between normal stem cells and cancer biology will also be explored. Fees range from $725 to $1,220, with reduced prices for guests.
Scale-Up and Manufacturing of Cell-Based Therapies
Engineering Conferences International (ECI)
Jan. 18-22, 2015
San Diego, CA
www.engconf.org
ECI’s fourth annual conference on manufacturing cell-based therapies is co-sponsored by the International Society for Cellular Therapy. It will focus on process development, scale-up, and manufacturing of cell-based therapies and will bring academicians, clinicians, industry leaders, and regulators together to discuss the critical scientific and engineering challenges in this field. The conference aims to define and refine the engineering sciences of cell-based therapies.
RegenMed Advanced Therapies State of the Industry Briefing
Alliance for Regenerative Medicine (ARM)
Jan. 12, 2015
San Francisco, CA
www.alliancerm.org
ARM’s 5th Annual Regenerative Medicine & Advanced Therapies States of the Industry Briefing is a top-level gathering for business executives, investors, patient advocates and academic leaders to learn more about recent advances and the outlook for the industry in the coming year. The event is free and open to the public but requires an RSVP for reservations.
Regen Med & Advanced Therapies State of the Industry Briefing
Alliance for Regenerative Medicine (ARM)
Jan. 12, 2015
San Francisco, CA
www.alliancerm.org
ARM’s 5th Annual Regenerative Medicine & Advanced Therapies States of the Industry Briefing is a top-level gathering for business executives, investors, patient advocates and academic leaders to learn more about recent advances and the outlook for the industry in the coming year. The event is free and open to the public but requires an RSVP for reservations.